Moderna receives $176 million from BARDA for mRNA influenza vaccines
STAT
JULY 2, 2024
Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to accelerate development of messenger RNA-based pandemic influenza vaccines, the company announced in a statement Tuesday. Read the rest…
Let's personalize your content